01PePeptidesENHANCED

Personalized GLP-1 for Virginia residents · US-licensed clinicians

See if I qualify
GLP-1 Access GuideVirginia · VAReviewed June 2026

Online GLP-1 Programs in Virginia

Virginia is the twelfth-largest state and one of the few that kept Medicaid coverage of GLP-1s for weight loss while many states retreated, though it tightened the rules. Coverage runs through strict prior authorization, so access still hinges on meeting specific BMI thresholds.

Population

8.8M

12th-largest state

Adult obesity

32.3%

2024 BRFSS

Diagnosed diabetes

12.9%

2024 BRFSS

Medicaid (weight loss)

Covered
See if you qualify with Yucca Health

From $129/mo · Ships in 2–4 days · Sponsored

Insurance

Does Virginia Medicaid cover GLP-1s?

Virginia Medicaid (DMAS) is one of the few state programs that covers GLP-1s for weight loss, backed by a 2025 budget appropriation of roughly $47 million for anti-obesity drugs (Virginia HB1600, 2025). Coverage is tightly controlled: the service-authorization criteria require a BMI of 40 or higher, or 35 or higher with two or more chronic conditions, plus a failed trial of a non-GLP-1 weight-loss drug (Virginia DMAS, 2025). GLP-1s for type 2 diabetes are covered separately. Unlike states that eliminated coverage in 2026, Virginia kept it but narrowed who qualifies.

Online Access

Getting a GLP-1 online in Virginia

GLP-1s are not controlled substances, so Virginia allows them to be prescribed via telehealth without a prior in-person exam when the standard of care is met (Virginia Board of Medicine). The prescriber must hold a Virginia license, so national telehealth platforms serve Virginia residents through a Virginia-licensed clinician.

Compounding

Compounded semaglutide & tirzepatide in Virginia

Routine compounding of semaglutide and tirzepatide ended after the FDA resolved the shortages in early 2025 (FDA, 2025). Virginia adds no special carve-out beyond the federal 503A/503B framework, so compounding is limited to documented, patient-specific clinical need.

Demand

Where GLP-1 demand is highest in Virginia

About 32% of Virginia adults have obesity and roughly 13% have diagnosed diabetes (CDC BRFSS via America's Health Rankings, 2024). Demand concentrates in Northern Virginia, part of the Washington, D.C. metro, plus Hampton Roads around Virginia Beach and Norfolk, and Richmond. Virginia's decision to keep Medicaid coverage, even under strict criteria, gives qualifying residents a public-payer path most states no longer offer.

Northern VirginiaVirginia Beach–NorfolkRichmondRoanokeLynchburgCharlottesville

Questions

Virginia GLP-1 FAQ

Does Virginia Medicaid cover Wegovy or Zepbound?

Yes, but with strict criteria. Virginia DMAS covers weight-loss GLP-1s for members with a BMI of 40 or higher, or 35 or higher with two or more chronic conditions, after a failed trial of a non-GLP-1 weight-loss drug (Virginia DMAS, 2025). Diabetes coverage is separate.

Can I get a GLP-1 prescribed online in Virginia?

Yes, by a Virginia-licensed clinician. The Board of Medicine permits telehealth prescribing without a prior in-person exam when the standard of care is met.

Is compounded tirzepatide available in Virginia?

Only narrowly. Routine compounding ended after the FDA resolved the shortages in 2025, and Virginia follows the federal rules with no special carve-out.

Telehealth, no insurance needed

Personalized GLP-1 for Virginia residents

Skip the coverage maze. Yucca Health connects Virginia residents with US-licensed clinicians for personalized GLP-1 treatment, from $129/mo.

See if you qualify

Sponsored · Affiliate disclosure

Educational information only, not medical or legal advice and not a substitute for a licensed clinician. GLP-1 coverage, telehealth, and compounding rules vary by state and change frequently; verify the current rules for your state before starting treatment. Links to Yucca Health are sponsored. Last reviewed 2026-06-13.